Morbus Alzheimer: Antikörper Solanezumab ohne Wirkung im präklinischen Stadium

Article Properties
Refrences
Title Journal Journal Categories Citations Publication Date
Trial of Solanezumab in Preclinical Alzheimer‘s Disease New England Journal of Medicine
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2023
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)3
Medicine: Internal medicine1
The category Medicine: Medicine (General) 3 is the most frequently represented among the references in this article. It primarily includes studies from New England Journal of Medicine The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year